Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-30,318
Closed -$3.44M 130
2024
Q2
$3.44M Sell
30,318
-2,938
-9% -$371K 1.12% 23
2024
Q1
$4.61M Sell
33,256
-800
-2% -$101K 1.55% 19
2023
Q4
$4.23M Sell
34,056
-522
-2% -$53.3K 1.54% 21
2023
Q3
$3.23M Buy
34,578
+41
+0.1% +$4.62K 1.29% 22
2023
Q2
$4.44M Sell
34,537
-165
-0.5% -$20K 1.66% 18
2023
Q1
$4.03M Sell
34,702
-651
-2% -$72.9K 1.6% 19
2022
Q4
$4M Buy
35,353
+107
+0.3% +$11.7K 1.71% 19
2022
Q3
$2.84M Sell
35,246
-14,782
-30% -$1.25M 1.34% 23
2022
Q2
$3.73M Sell
50,028
-1,084
-2% -$98.9K 1.68% 17
2022
Q1
$6.54M Sell
51,112
-632
-1% -$69.1K 2.37% 11
2021
Q4
$6.95M Sell
51,744
-884
-2% -$127K 2.15% 12
2021
Q3
$7.2M Sell
52,628
-1,808
-3% -$228K 2.69% 10
2021
Q2
$5.81M Sell
54,436
-16
-0% -$1.54K 2.16% 14
2021
Q1
$4.89M Sell
54,452
-3,824
-7% -$359K 2.09% 13
2020
Q4
$5.39M Buy
58,276
+16,172
+38% +$1.44M 2.22% 11
2020
Q3
$4.34M Sell
42,104
-308
-0.7% -$32.2K 2.04% 12
2020
Q2
$4.3M Buy
42,412
+9,004
+27% +$805K 2.35% 9
2020
Q1
$2.25M Buy
33,408
+3,928
+13% +$244K 1.63% 18
2019
Q4
$1.61M Buy
29,480
+500
+2% +$23.7K 0.96% 32
2019
Q3
$1.08M Buy
28,980
+1,792
+7% +$69.6K 0.74% 34
2019
Q2
$1.02M Buy
27,188
+2,040
+8% +$64.1K 0.72% 32
2019
Q1
$749K Buy
25,148
+8,300
+49% +$292K 0.58% 38
2018
Q4
$505K Buy
+16,848
New +$534K 0.5% 41

Other funds holding DXCM

Knuff & Co's DXCM Position: Q3 2024 in Review

Knuff & Co sold out of DexCom (DXCM) in Q3 2024, closing a stake of 30,318 shares — an estimated $3.44M sold.

Knuff & Co first reported a position in DXCM in Q4 2018 and held it in 23 quarters. The position peaked at $7.2M in Q3 2021. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Knuff & Co reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Knuff & Co sold 30,318 DexCom shares in Q3 2024, an estimated $3.44M.
  • Knuff & Co first reported a position in DexCom in Q4 2018 and held it in 23 quarters.
  • Knuff & Co's DexCom position peaked at $7.2M in Q3 2021.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Knuff & Co's 13F filing for Q3 2024, filed 7 Nov 2024.